Nypozi Injection
Product Images NDC 72374-102

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Nypozi (NDC 72374-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tanvex Biopharma Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Nypozi 01)

An instructional diagram showing the parts and usage stages of a NYPOZI txid 300 ug/300ug injection syringe pre- and post-use. Labels identify components including the gray needle cap, needle guard with wings, dose markings, plunger stopper and head, finger grips, and a viewing window for expiration and lot number. The 'AFTER USE' image illustrates the extended needle guard and removed gray needle cap.*

FDA Label Image

Image (Nypozi 02)

An instructional illustration showing a hand holding a syringe with a needle guard. Two black arrows indicate the action to 'GRAB NEEDLE GUARD,' highlighting a step in preparing or using the syringe for injection.*

FDA Label Image

Image (Nypozi 03)

Illustration of a prefilled syringe for NYPOZI txid (filgrastim-txid) injection, showing key parts: gray needle cap, dose markings on the barrel ranging from 0 to 0.5 mL, a viewing window displaying the label with expiration date and lot number, and the plunger for administering the dose.*

FDA Label Image

Image (Nypozi 04)

An illustration of a prefilled syringe device for NYPOZI txid (filgrastim-txid) injection, showing internal components including the plunger, barrel with volume markings up to 0.5 mL, needle, and stopper, intended for intravenous or subcutaneous administration.*

FDA Label Image

Image (Nypozi 05)

An illustrated diagram showing five items arranged horizontally: a syringe on the far left followed by an alcohol wipe, a cotton ball, an adhesive bandage, and a biohazard sharps disposal container. Each item is labeled below its respective image. The sharps container has a biohazard symbol and the word 'SHARPS' above it.*

FDA Label Image

Image (Nypozi 06)

An instructional illustration showing recommended body sites for injection. Marked areas for injection include the upper arm, stomach area (abdomen), thigh, and buttocks, with front and back views of a human figure for guidance.*

FDA Label Image

Image (Nypozi 07)

An instructional diagram showing a hand holding a syringe for NYPOZI txid (filgrastim-txid) injection, with the other hand removing a protective needle cap by pulling it upward. A smaller inset shows proper disposal of the needle cap into a sharps container labeled with a biohazard symbol.*

FDA Label Image

Image (Nypozi 08)

FDA Label Image

Image (Nypozi 09)

An instructional line drawing illustrating the proper use or handling of an injection device, showing a hand holding the syringe and the other hand performing an action with fingers. The drawing emphasizes the syringe's plunger and dosage scale.*

FDA Label Image

Image (Nypozi 10)

Illustration showing the steps to adjust the dose on a NYPOZI txid (filgrastim-txid) prefilled injection device. It demonstrates holding the syringe and moving the plunger from the initial position with dose lines marked, to the setting of a partial dose indicated by the top edge of the conical base aligning with the chosen dose line.*

FDA Label Image

Image (Nypozi 11)

An instructional illustration showing a hand pinching abdominal skin with arrows indicating the pinching motion. This image likely depicts a technique for preparing the skin for subcutaneous injection.*

FDA Label Image

Image (Nypozi 12)

An instructional illustration showing hands administering an injection subcutaneously. The image depicts a syringe held at a 45-degree angle relative to the skin surface with an arrow indicating the needle insertion direction. An inset shows an angle range from 45 degrees to 90 degrees, emphasizing proper injection angle.*

FDA Label Image

Image (Nypozi 13)

An instructional illustration showing two hands, one holding a device and the other positioned to receive an injection or dose, with an arrow indicating the direction to push or dispense. This image likely demonstrates the administration or use of an injection device.*

FDA Label Image

Image (Nypozi 14)

An instructional illustration showing proper technique for using a syringe to inject a medication subcutaneously. The image depicts one hand holding the syringe, positioned at an angle, and the other hand pinching the skin to prepare for injection.*

FDA Label Image

Image (Nypozi 15)

FDA Label Image

Image (Nypozi 16)

An instructional line drawing showing a hand holding a prefilled syringe with a needle cover, illustrating the proper grip for administering an injection. The syringe barrel is transparent with visible measurement markings. No text or labeling is present in the image.*

FDA Label Image

Image (Nypozi 17)

An instructional illustration showing a hand disposing of a sharps object into a container labeled "SHARPS" with a biohazard symbol, indicating safe disposal of needles or syringes.*

FDA Label Image

Principal Display Panel ((1) 0.5 mL Syringe Carton)

Packaging label for NYPOZI (filgrastim-txid) injection 300 mcg/0.5 mL single-dose prefilled syringe by Tanvex BioPharma USA, Inc. The label indicates intravenous and subcutaneous use, includes storage instructions, ingredient details, and warnings. The carton design includes the product name, strength, manufacturer, barcode, and NDC 72374-101-01.*

FDA Label Image

Principal Display Panel ((10) 0.5 mL Syringe Carton)

Packaging label for NYPOZI (filgrastim-txid) injection 300 mcg/0.5 mL single-dose prefilled syringes. The carton contains 10 syringes with needle guards. Manufactured by Tanvex BioPharma USA, Inc., the label indicates the product is for subcutaneous or intravenous use only and does not contain latex, preservatives, or require freezing. Storage instructions and ingredients are also included on the label.*

FDA Label Image

Principal Display Panel ((1) 0.5 mL Syringe Carton)

NYPOZI txid 480 mcg/0.8 mL injection single-dose prefilled syringe packaging label. The label displays the proprietary name NYPOZI with generic filgrastim-txid, specifying intravenous and subcutaneous injection routes. It provides the concentration of 480 mcg/0.8 mL and includes manufacturer information for Tanvex BioPharma USA, Inc. The label notes product storage instructions and that it contains no latex or preservative.*

FDA Label Image

Principal Display Panel ((10) 0.5 mL Syringe Carton)

Packaging label for NYPOZI (filgrastim-txid) injection, 480 mcg/0.8 mL, a single-dose prefilled syringe. The label indicates it is manufactured by Tanvex BioPharma USA, Inc. and includes instructions for subcutaneous or intravenous use. The packaging is designed for a 10-count box of syringes with needle guard.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.